Kewaspadaan Penyakit Dementia Melalui Edukasi Gaya Hidup Dan Skrining Albuminuria, Low-Density Lipoprotein (Ldl), Serta Asam Urat
DOI:
https://doi.org/10.56910/sewagati.v2i2.640Keywords:
dementia, early detection, counseling, LDL, uric acid, MMSE, albuminuriaAbstract
Dementia is a neurodegenerative condition that causes a progressive decline in a person's cognitive abilities. Education about dementia and its risk factors has an important role in increasing public understanding of this condition. With increased awareness, individuals can adopt a healthy lifestyle and reduce the risk of developing dementia. In addition, counseling also helps reduce stigma and discrimination, and provides better social support to individuals with dementia. Early detection of dementia through tests such as the Mini-Mental State Examination (MMSE), albuminuria, Low-Density Lipoprotein (LDL), and uric acid is also important. Cognitive tests such as the MMSE are helpful in identifying cognitive problems early, while screening biomarkers such as albuminuria, LDL and uric acid can reveal risk factors associated with dementia. Community service activities involved 52 productive age respondents. Community service activities begin with outreach activities regarding dementia and related risk factors, and are continued with physical and supporting examinations. The results of supporting examinations revealed that no one had dementia, but there were 6 (11.5%) respondents who had elevated LDL, and 1 (1.9%) respondent had hyperuricemia and albuminuria). With early detection, individuals can take more effective preventive measures and initiate appropriate management, thus improving their quality of life. Overall, counseling and early detection of dementia have an important role in preventing, managing and improving the quality of life of individuals affected by dementia.
References
A Pujarini, L. (2009). Dislipidemia pada Penderita Stroke dengan Demensia di RS Dr. Sardjito Jogjakarta.
Alzheimer’s Disease International. (2021). Dementia statistics. Alzheimer’s Disease International. https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/
Bikbov, B., Soler, M. J., Pešić, V., Capasso, G., Unwin, R., Endres, M., Remuzzi, G., Perico, N., Gansevoort, R., & Mattace-Raso, F. (2022). Albuminuria as a risk factor for mild cognitive impairment and dementia—what is the evidence? Nephrology Dialysis Transplantation, 37(Supplement_2), ii55–ii62.
Creavin, S. T., Wisniewski, S., Noel‐Storr, A. H., Trevelyan, C. M., Hampton, T., Rayment, D., Thom, V. M., Nash, K. J. E., Elhamoui, H., & Milligan, R. (2016). Mini‐Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database of Systematic Reviews, 1.
Feldman, H. H., Jacova, C., Robillard, A., Garcia, A., Chow, T., Borrie, M., Schipper, H. M., Blair, M., Kertesz, A., & Chertkow, H. (2008). Diagnosis and treatment of dementia: 2. Diagnosis. Cmaj, 178(7), 825–836.
Gao, S., Burney, H. N., Callahan, C. M., Purnell, C. E., & Hendrie, H. C. (2019). Incidence of dementia and Alzheimer disease over time: A meta‐analysis. Journal of the American Geriatrics Society, 67(7), 1361–1369.
Georgakis, M. K., Dimitriou, N. G., Karalexi, M. A., Mihas, C., Nasothimiou, E. G., Tousoulis, D., Tsivgoulis, G., & Petridou, E. T. (2017). Albuminuria in association with cognitive function and dementia: A systematic review and meta‐analysis. Journal of the American Geriatrics Society, 65(6), 1190–1198.
González-Aramburu, I., Sánchez-Juan, P., Sierra, M., Fernández-Juan, E., Sánchez-Quintana, C., Berciano, J., Combarros, O., & Infante, J. (2014). Serum uric acid and risk of dementia in Parkinson’s disease. Parkinsonism & Related Disorders, 20(6), 637–639.
Iwagami, M., Qizilbash, N., Gregson, J., Douglas, I., Johnson, M., Pearce, N., Evans, S., & Pocock, S. (2021). Blood cholesterol and risk of dementia in more than 1• 8 million people over two decades: a retrospective cohort study. The Lancet Healthy Longevity, 2(8), e498–e506.
Khan, A. A., Quinn, T. J., Hewitt, J., Fan, Y., & Dawson, J. (2016). Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis. Age, 38, 1–11.
Kivipelto, M., Solomon, A., Ahtiluoto, S., Ngandu, T., Lehtisalo, J., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., & Laatikainen, T. (2013). The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER): study design and progress. Alzheimer’s & Dementia, 9(6), 657–665.
Li, L., Willets, R. S., Polidori, M. C., Stahl, W., Nelles, G., Sies, H., & Griffiths, H. R. (2010). Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance. Free Radical Research, 44(3), 241–248.
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., & Cohen-Mansfield, J. (2017). Dementia prevention, intervention, and care. The Lancet, 390(10113), 2673–2734.
Middleton, L. E., & Yaffe, K. (2009). Promising strategies for the prevention of dementia. Archives of Neurology, 66(10), 1210–1215.
Mutiara, P. U. (2021). Asuhan Keperawatan Jiwa Pada Tn. B Dengan Gangguan Sensori Persepsi: Halusinasi Pendengaran Di Ruangan Merpati RSJ. Prof. HB. Saanin Padang Tahun 2021. Stikes Alifah Padang.
Ouanes, S., & Popp, J. (2019). High cortisol and the risk of dementia and Alzheimer’s disease: a review of the literature. Frontiers in Aging Neuroscience, 11, 43.
Overshott, R., & Burns, A. (2005). Treatment of dementia. Journal of Neurology, Neurosurgery & Psychiatry, 76(suppl 5), v53–v59.
Prince, M., Guerchet, M., & Prina, M. (2015). The epidemiology and impact of dementia-current state and future trends. WHO Thematic Briefing.
Rasmussen, J., & Langerman, H. (2019). Alzheimer’s disease–why we need early diagnosis. Degenerative Neurological and Neuromuscular Disease, 123–130.
Sathianathan, R., & Kantipudi, S. J. (2018). The dementia epidemic: Impact, prevention, and challenges for India. Indian Journal of Psychiatry, 60(2), 165.
Tisher, A., & Salardini, A. (2019). A comprehensive update on treatment of dementia. Seminars in Neurology, 39(02), 167–178.
Wimo, A., Jönsson, L., Bond, J., Prince, M., Winblad, B., & International, A. D. (2013). The worldwide economic impact of dementia 2010. Alzheimer’s & Dementia, 9(1), 1–11.
Yousaf, K., Mehmood, Z., Awan, I. A., Saba, T., Alharbey, R., Qadah, T., & Alrige, M. A. (2020). A comprehensive study of mobile-health based assistive technology for the healthcare of dementia and Alzheimer’s disease (AD). Health Care Management Science, 23, 287–309.
Zhou, Z., Zhong, S., Liang, Y., Zhang, X., Zhang, R., Kang, K., Qu, H., Xu, Y., Zhao, C., & Zhao, M. (2021). Serum uric acid and the risk of dementia: a systematic review and meta-analysis. Frontiers in Aging Neuroscience, 13, 625690.
